| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, W Richard Staine. Discontinuing cannabis improves depression in people with multiple sclerosis: A short report. Multiple sclerosis (Houndmills, Basingstoke, England). vol 27. issue 4. 2021-09-24. PMID:32589554. |
to assess whether symptoms of depression change when people with multiple sclerosis (pwms) discontinue cannabis use, 40 cognitively impaired pwms who smoked cannabis almost daily were randomly assigned to either a cannabis continuation (cc) or cannabis withdrawal (cw) group. |
2021-09-24 |
2023-08-13 |
human |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, William R Staine. Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary. Brain and behavior. vol 11. issue 8. 2021-09-22. PMID:34087949. |
impaired awareness: why people with multiple sclerosis continue using cannabis despite evidence to the contrary. |
2021-09-22 |
2023-08-13 |
Not clear |
| Anthony Feinstein, Cecilia Meza, Cristiana Stefan, William R Staine. Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary. Brain and behavior. vol 11. issue 8. 2021-09-22. PMID:34087949. |
with widespread moves toward legalization of cannabis, increasing numbers of people with multiple sclerosis (pwms) are using the drug. |
2021-09-22 |
2023-08-13 |
Not clear |
| Sven G Meuth, Thomas Henze, Ute Essner, Christiane Trompke, Carlos Vila Silvá. Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial. The International journal of neuroscience. vol 130. issue 12. 2021-08-16. PMID:32065006. |
tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the savant randomized clinical trial. |
2021-08-16 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Jason R B Dyc. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. vol 69. issue 11. 2021-08-04. PMID:32860528. |
the pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards. |
2021-08-04 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Jason R B Dyc. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. vol 69. issue 11. 2021-08-04. PMID:32860528. |
despite the fact that the risk versus benefit of smoking cannabis has not been extensively studied, many individuals with multiple sclerosis are smoking cannabis to reduce their pain intensity and spasticity. |
2021-08-04 |
2023-08-13 |
Not clear |
| Zaid H Maayah, Jason R B Dyc. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. vol 69. issue 11. 2021-08-04. PMID:32860528. |
given the fact that the administration of cannabis via inhalation is known to rapidly deliver cannabinoids with a higher total bioavailability than what can be achieved through oral or buccal routes, it is important to understand the clinical trials conducted using smoked cannabis on patients with multiple sclerosis. |
2021-08-04 |
2023-08-13 |
Not clear |
| Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, Fabiola Atzeni, Sara Bongiovanni, Piercarlo Sarzi-Puttin. Cannabis and Autoimmunity: Possible Mechanisms of Action. ImmunoTargets and therapy. vol 10. 2021-07-30. PMID:34322454. |
in this review, we summarized the main mechanisms of action of medical cannabis plant especially regarding the immune system and the endocannabinoid system, looking at preliminary clinical data in three most important autoimmune diseases of three different specialities: rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. |
2021-07-30 |
2023-08-13 |
human |
| Edgar Carnero Contentti, Pablo A López, Juan Criniti, Juan Pablo Pettinicchi, Dario Tavolini, Carolina Mainella, Santiago Tizio, Verónica Tkachuk, Berenice Silva, Alejandro Caride, Juan I Rojas, Ricardo Alons. Use of cannabis in patients with multiple sclerosis from Argentina. Multiple sclerosis and related disorders. vol 51. 2021-07-07. PMID:33848817. |
use of cannabis in patients with multiple sclerosis from argentina. |
2021-07-07 |
2023-08-13 |
Not clear |
| Edgar Carnero Contentti, Pablo A López, Juan Criniti, Juan Pablo Pettinicchi, Dario Tavolini, Carolina Mainella, Santiago Tizio, Verónica Tkachuk, Berenice Silva, Alejandro Caride, Juan I Rojas, Ricardo Alons. Use of cannabis in patients with multiple sclerosis from Argentina. Multiple sclerosis and related disorders. vol 51. 2021-07-07. PMID:33848817. |
the use of cannabis to treat some symptoms of neurological diseases, including multiple sclerosis (ms), has increased worldwide. |
2021-07-07 |
2023-08-13 |
Not clear |
| Ping Gao, Yuxian Chen, Chongrong Ke, Xinwei Yang, Jianzhong Huan. [New targeted compounds-biosynthesis of phytocannabinoids]. Sheng wu gong cheng xue bao = Chinese journal of biotechnology. vol 37. issue 6. 2021-07-07. PMID:34227288. |
at present, Δ9-tetrahydrocannabinol, cannabidiol and their analogues or combination preparations are used to treat epilepsy, vomiting in patients with cancer chemotherapy, spasticity in multiple sclerosis and relieve neuropathic pain and pain in patients with advanced cancer. |
2021-07-07 |
2023-08-13 |
human |
| Joseph L Damstra-Oddy, Eleanor C Warren, Christopher J Perry, Yann Desfougères, John-Mark K Fitzpatrick, Judith Schaf, Lisa Costelloe, William Hind, Eric J Downer, Adolfo Saiardi, Robin S B William. Phytocannabinoid-dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity. British journal of pharmacology. vol 178. issue 5. 2021-07-05. PMID:33347604. |
cannabidiol (cbd) has been shown to differentially regulate the mechanistic target of rapamycin complex 1 (mtorc1) in preclinical models of disease, where it reduces activity in models of epilepsies and cancer and increases it in models of multiple sclerosis (ms) and psychosis. |
2021-07-05 |
2023-08-13 |
Not clear |
| James M Nichols, Evangel Kummari, Jessica Sherman, Eun-Ju Yang, Saphala Dhital, Christa Gilfeather, Gabriella Yray, Timothy Morgan, Barbara L F Kapla. CBD Suppression of EAE Is Correlated with Early Inhibition of Splenic IFN-γ + CD8+ T Cells and Modest Inhibition of Neuroinflammation. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 16. issue 2. 2021-06-18. PMID:32440886. |
in this study cannabidiol (cbd) was administered orally to determine its effects and mechanisms in the experimental autoimmune encephalomyelitis (eae) model of multiple sclerosis (ms). |
2021-06-18 |
2023-08-13 |
mouse |
| Alessia Furgiuele, Marco Cosentino, Marco Ferrari, Franca Marin. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. vol 16. issue 2. 2021-06-18. PMID:33492630. |
immunomodulatory potential of cannabidiol in multiple sclerosis: a systematic review. |
2021-06-18 |
2023-08-13 |
human |
| Brian Kaskie, Hyojung Kang, Divya Bhagianadh, Julie Bobit. Cannabis Use among Older Persons with Arthritis, Cancer and Multiple Sclerosis: Are We Comparing Apples and Oranges? Brain sciences. vol 11. issue 5. 2021-05-27. PMID:33922425. |
cannabis use among older persons with arthritis, cancer and multiple sclerosis: are we comparing apples and oranges? |
2021-05-27 |
2023-08-13 |
Not clear |
| Yara Dadalti Fragoso, Adriana Carra, Miguel Angel Macia. Cannabis and multiple sclerosis. Expert review of neurotherapeutics. vol 20. issue 8. 2021-05-17. PMID:32515670. |
cannabis and multiple sclerosis. |
2021-05-17 |
2023-08-13 |
Not clear |
| José María Prieto González, Carlos Vila Silvá. Safety and tolerability of nabiximols oromucosal spray: a review of real-world experience in observational studies, registries, and case reports. Expert review of neurotherapeutics. vol 21. issue 5. 2021-05-17. PMID:33749480. |
: nabiximols oromucosal spray,a cannabis-based medicine containing a balanced ratio of Δ-9-tetrahydrocannabinol and cannabidiol, is approved widely as an add-on therapy for symptomatic relief of spasticity in people with multiple sclerosis (ms). |
2021-05-17 |
2023-08-13 |
Not clear |
| Susan L Calcaterra, Chinazo O Cunningham, Christian J Hopfe. The Void in Clinician Counseling of Cannabis Use. Journal of general internal medicine. vol 35. issue 6. 2021-05-14. PMID:31898125. |
observational data supports the use of cannabis for pain, nausea and vomiting related to chemotherapy, and multiple sclerosis spasticity symptoms. |
2021-05-14 |
2023-08-13 |
Not clear |
| Gustavsen S, Søndergaard Hb, Linnet K, Thomsen R, Rasmussen Bs, Sorensen Ps, Sellebjerg F, Oturai A. Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. Multiple sclerosis and related disorders. vol 48. 2021-05-14. PMID:33387864. |
safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. |
2021-05-14 |
2023-08-13 |
Not clear |
| Gustavsen S, Søndergaard Hb, Linnet K, Thomsen R, Rasmussen Bs, Sorensen Ps, Sellebjerg F, Oturai A. Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis. Multiple sclerosis and related disorders. vol 48. 2021-05-14. PMID:33387864. |
the use of cannabis as medical therapy to treat chronic pain and spasticity in patients with multiple sclerosis (ms) is increasing. |
2021-05-14 |
2023-08-13 |
Not clear |